BC Cancer Surrey and University of British ColumbiaCalgary, AB
Disclosure information not submitted.
1040 - Development of Nomograms to Predict Polymetastatic Progression Free Survival and Overall Survival in Patients Treated with Stereotactic Ablative Radiotherapy for Oligometastatic or Oligoprogressive Ca
Tuesday, October 1, 20248:25 AM – 8:30 AM ET
